Ares Capital Corporation's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Operating-Expenses" stands at 107.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Ares Capital Corporation's third quarter result of 29.00 Million USD for the item "Operating Expenses" represents no change compared to it's second quarter result.
Also, Ares Capital Corporation's third quarter result of 29.00 Million USD for the item "Operating Expenses" represents an increase of 11.54 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Ares Capital Corporation's third quarter result of 107.00 Million USD for the item "Operating Expenses" represents an increase of 2.88 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -5.00 Million United States Dollars compared to the value the year prior.
The 1 year change is -5.00 Million United States Dollars.
The 3 year change is -39.00 Million United States Dollars.
The 5 year change is 30.00 Million United States Dollars.
The 10 year change is 58.90 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Operating Expenses | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Operating Expenses | 186,696,990,720.00 |
![]() | BlackRock Inc - Operating Expenses | 166,346,604,544.00 |
![]() | KKR & Co LP - Operating Expenses | 119,832,821,760.00 |
![]() | BioPharma Credit PLC - Operating Expenses | 101,856,345,600.00 |